Neuropathic pain is characterized by abnormal hypersensitivity to stimuli (hyperalgesia) and
nociceptive responses to non-noxious stimuli (allodynia). The conditions and the …

Neuropathic pain, caused by a lesion or disease affecting the somatosensory system, affects
between 3 and 17% of the general population. The treatment of neuropathic pain is …

Pharmacology and treatment of neuropathic pains : Current Opinion in Neurology
Pharmacology and treatment of neuropathic pains : Current Opinion in Neurology Log in or …

Abstract Purpose of Review: Neuropathic pain (NP) is caused by a lesion of the
somatosensory system and is characterized by a combination of positive symptoms …

Neuropathic pain affects more than one million people across the globe. The quality of life of
people suffering from neuropathic pain has been considerably declining due to the …

Neuropathic pain, comprising a range of heterogeneous conditions, is often severe and
difficult to manage, and this may result in a chronic condition that negatively affects the …

Neuropathic pain is a personally devastating and costly condition affecting 3–8% of the
population. Existing treatments have limited effectiveness and produce relatively frequent …

Neuropathic pain, caused or initiated by a primary lesion in the peripheral or central nervous
system, can result in a dramatic reduction in the patient's quality of life. The expression …

Neuropathic pain is caused by a lesion or disease of the somatosensory system, including
peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7–10% of the …

Neuropathic pain is a chronic pain condition caused by a primary lesion or dysfunction in the
nervous system. It can be a consequence of many different insults, such as trauma, neuronal …